AI-Powered Precision Measures: A Golden Opportunity for Clinical Research
As the cost of developing new therapies continues to rise, pharma executives must turn to technologies that drive better insights into de-risked investments and produce…
As the cost of developing new therapies continues to rise, pharma executives must turn to technologies that drive better insights into de-risked investments and produce…
Robert Gaertner, Vice President of Quality Strategy Europe at Veeva Systems, discusses the growing importance of connected platforms in ensuring quality in pharmaceutical manufacturing and…
Regulatory workloads now far exceed the pace of company growth, but assigning more people to the tasks isn’t an option, which in turn is driving…
While AI in the pharma cold chain promises exciting possibilities, achieving these benefits is not a sprint but a marathon. The journey towards fully integrating…
Adverse event (AE) case intake in Life Sciences is crying out for disruption by AI. And now, at last, Generative AI and Large Language Models…
Medical writing in pharma is ripe for disruption, across use cases linked to regulatory documentation and safety report summaries, and Generative AI (GenAI) promises exactly…
Smart automation promises to transform life sciences research and development operations, and streamline pharma companies’ path to market while enhancing patient safety. But how far…
We’re in a new era of biotech, defined by the interplay between biology, data and AI. And it’s the enabling technologies — the connected instruments,…
The breakneck pace of digital transformation spurred by COVID-19 continued to reshape the life sciences landscape in 2023. Rather than a single watershed moment, this…
Neo4j’s Alexander Jarasch explains how to get the best from ChatGPT-like tools, while safeguarding intellectual property ChatGPT has delivered a natural language understanding (NLU) interface…